Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aiming to promote the development of plastic surgery and enhance collaboration among related disciplines [2][3]. Conference Overview - The conference will feature a main forum, an innovation transformation competition final, and nine sub-forums, with an expected attendance of around 500 participants [2]. - The event will include product exhibitions from various companies, and registration is free for attendees [2]. Main Forum Agenda - The main forum will commence with a welcome address and opening speeches from key figures in the medical and academic fields, including the Vice President of the Chinese Academy of Medical Sciences and the Chairman of the Beijing Eight Major Places Plastic Surgery Medical Technology Group [2]. - The agenda includes a series of thematic presentations covering topics such as the introduction of the Eight Major Places Plastic Surgery Medical Concept Verification Center, innovative medical technologies, and the commercialization of medical device innovations [3]. Innovation Transformation Competition - The afternoon session will host the third Plastic Surgery Innovation Transformation Competition final, showcasing innovative projects in plastic surgery and aesthetic medicine, providing a platform for clinical innovation [3]. Investment Forum - A dedicated investment sub-forum will take place on November 2, featuring discussions on the current state and opportunities in the aesthetic medicine industry, as well as trends in the light medical beauty sector [3][4]. - Notable speakers include investment managers and industry leaders who will share insights on various topics, including stem cell applications and the development of high-end domestic laser medical equipment [4]. Additional Sub-Forums - The conference will also host several sub-forums focusing on topics such as medical device safety and compliance, high-quality development of aesthetic institutions, and digital transformation in the medical beauty industry [4][5].

Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aimed at promoting the development of plastic surgery in China and enhancing collaboration among related disciplines [3]. Event Details - The event will feature the Third Ba Da Chu Aesthetic Industry Forum, a competition final, and nine sub-forums [3]. - Participation is free, and there will be an exhibition of enterprise products on-site [4]. Hosting Organizations - The event is organized by Ba Da Chu Plastic Surgery Medical Concept Verification Center, Si Yu MedTech, Jin Yu Mao Wu, Tsinghua Technology Park Medical Engineering Cross-Innovation Center, and Zi Niu Fund [5]. Morning Session Highlights - The morning session includes various presentations, such as: - "Investment Perspective on the Current Status and Opportunities in the Medical Aesthetic Industry" by Sun Haisun, Investment Deputy General Manager, Jin Yu Mao Wu [5]. - "Trends in the Development of the Light Medical Aesthetic Industry" by Yu Bo, Partner, Zi Niu Fund [5]. - "Application of Stem Cells and Exosomes in Postoperative Wound Repair" by Zhao Yong, Chairman, Beizheng Saiou (Beijing) Biotechnology Co., Ltd. [5]. Afternoon Session Highlights - The afternoon session will cover topics including: - "Opportunities and Challenges for Domestic Medical Aesthetic Photonic Equipment Going Abroad" by Liao Ziyan, Brand Promotion Director, Suzhou Baifu Laser Technology Co., Ltd. [6]. - "New Generation Needle-Free Drug Delivery Technology in Domestic and International Medical Aesthetic Fields" by Zhou Ping, CTO, Zhuoyou Medical (Suzhou) Co., Ltd. [6]. - "Applications of Functional Nucleic Acid Nanotechnology in the Light Medical Aesthetic Industry" by Zhang Kaiping, Marketing Center General Manager, Beijing Xingyilian Technology Co., Ltd. [6]. Registration Information - Interested participants can register by scanning a QR code or clicking a link provided at the end of the article [6].

2025年9月25日， 第二届医疗器械研发论坛 在 Medtec 2025 国际医疗器械设计与制造技术展览会 现场圆满举办。本次论坛由思宇MedTech组织，获得展会主办 方 英富曼集团 的大力支持。作为聚焦研发与制造的专业平台，Medtec 已经在中国成功举办19届，见证了中国医疗器械产业的成长与国际化。 赵清，思宇MedTech创始人，在论坛开场时表示："Medtec的特别之处在于它聚焦医疗器械的'源头'环节。这里不仅是展示窗口，更是推动行业交流与创新的加速 器。" # 开幕致辞：见证21年的医疗器械产业成长 顾晓媛，英富曼会展集团医疗健康&IP授权 总经理 顾总在致辞中强调，Medtec China 作为Medtech全球系列展的重要一站，已陪伴中国医疗器械产业二十余年， 是产业的加速器。展会与论坛的结合，正是促进产业交流与国际合作的关键形式。 # 医工融合与转化：医院与研发的连接 雷娟，四川西部医药技术转移中心 理事长/主任，中国医学装备协会医疗器械创新与应用分会 副会长 雷娟分享了华西医院的科技成果转化历程，医院不仅是临床 验证的场所，更是科技成果转化的源头。通过建立多学科交叉平台和成果转化机制，越 ...

Core Viewpoint - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2][3]. Agenda Summary Morning Session - Opening remarks will commence at 09:30, followed by various presentations including: - Exploration of medical-engineering integration in research hospitals by Lei Juan, highlighting innovation and transformation [2] - Discussion on new interventional technologies and related patents by Cao Gangyi, CEO of Huanxin Medical [2] - Successful practices in building multi-level medical technology clusters presented by Wang Hanxuan, a Swiss PSI scientist [2] - Research on vascular injury repair and regenerative materials by Wang Kai from Nankai University [2] - Current status and innovative thoughts on ultrasonic energy surgical instruments by Feng Gengchao, founder of Shenzhen Segasys Medical Technology [2] - Development and transformation of Chro-Mg™ time-controlled degradable magnesium alloy by Shi Chen, CEO of InnoCo [2]. Afternoon Session - The afternoon will feature additional presentations starting at 13:30, including: - Overview of the entire medical device R&D process and overseas case studies by Zhao Qing, founder of Siyu MedTech [3] - Key points on medical device testing and compliance standards by Shi Daifeng, Technical Director at China Inspection Huatuo [4] - Applications and efficacy of PDRN (salmon-derived beauty injections) in aesthetic implants by Zhou Gui, General Manager of Beijing Lila Technology [4] - Discussion on fully degradable stents for diabetic below-knee artery intervention by Han Chen, co-founder of Beijing Haisheng Medical Devices [4] - Exploration of the starting point for medical device innovation incubation by Zhang Bowei, CTO of Vascular Cube Medical Device Incubation Platform [4] - Trends in vascular reduction technology presented by Wang Yang, founder and General Manager of Jintai Medical [4] - Applications and practices of common polymer biomaterials in implantable medical devices by Guan Zenggang, R&D Director at Haiwang Medical [4] - AI-assisted planning for structural heart interventional surgeries by Xue Zhenling, General Manager of Xixin Technology [4].

Core Viewpoint - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2][3]. Morning Agenda Summary - The forum will feature various presentations, including topics such as the integration of medical engineering in research hospitals, new interventional technologies, and the development of biodegradable magnesium alloys [2][3][4]. - Key speakers include: - Lei Juan, discussing the exploration of innovation and transformation in medical engineering [2]. - Cao Gangyi, presenting on new interventional technologies and related patents [2]. - Wang Hanxuan, sharing successful practices from the Basel pharmaceutical valley [2]. - Wang Kai, focusing on vascular injury repair and regenerative materials [2]. - Feng Gengchao, addressing the current status and innovative thoughts on ultrasonic energy surgical instruments [2]. - Shi Chen, discussing the R&D and transformation of Chro-Mg™ controlled degradation magnesium alloys [2]. Afternoon Agenda Summary - The afternoon session will cover topics such as the full process of medical device R&D, compliance standards, and applications of PDRN in aesthetic medicine [3][4]. - Notable presentations include: - Zhao Qing, discussing the full process of medical device R&D and overseas cases [3]. - Shi Daifeng, sharing key points on medical device testing and compliance [4]. - Zhou Gui, presenting on the application and efficacy of PDRN in implantable agents [4]. - Han Chen, discussing the use of fully biodegradable stents for diabetic patients [4]. - Zhang Bowei, exploring the starting point for medical device innovation incubation [4]. - Wang Yang, addressing trends in vascular reduction technology [4]. - Guan Zenggang, discussing the application and practice of common polymer biomaterials in implantable medical devices [4]. - Xue Zhenling, presenting on AI-assisted planning for structural heart interventional surgeries [4].

Group 1 - The second Medical Device R&D Innovation Forum will be held during the Medtec China 2025 exhibition in Shanghai, focusing on product innovation pathways and implementation mechanisms [2] - The forum is organized by Siyu MedTech and Informa Markets' Medtec China team, inviting industry leaders and experts to share insights [2] - The agenda includes various presentations on topics such as medical technology integration, new intervention techniques, and the development of biodegradable materials [3][4] Group 2 - The morning session features speakers from various organizations discussing topics like the integration of medical engineering in research hospitals and innovations in surgical ultrasound devices [3] - The afternoon session includes discussions on high-quality development in the medical health industry and the application of PDRN in aesthetic medicine [4] - Attendees can register for free to participate in the forum by filling out a registration form [4]